BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 22552888)

  • 1. Rho-kinase inhibitor, fasudil, prevents neuronal apoptosis via the Akt activation and PTEN inactivation in the ischemic penumbra of rat brain.
    Wu J; Li J; Hu H; Liu P; Fang Y; Wu D
    Cell Mol Neurobiol; 2012 Oct; 32(7):1187-97. PubMed ID: 22552888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons.
    Yamashita K; Kotani Y; Nakajima Y; Shimazawa M; Yoshimura S; Nakashima S; Iwama T; Hara H
    Brain Res; 2007 Jun; 1154():215-24. PubMed ID: 17482584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatment with an oral rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats.
    Li WJ; Park K; Paick JS; Kim SW
    J Sex Med; 2011 Feb; 8(2):400-10. PubMed ID: 20233282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis.
    Takata M; Tanaka H; Kimura M; Nagahara Y; Tanaka K; Kawasaki K; Seto M; Tsuruma K; Shimazawa M; Hara H
    Br J Pharmacol; 2013 Sep; 170(2):341-51. PubMed ID: 23763343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyl fasudil, an inhibitor of Rho signaling, improves erectile function in diabetic rats: a role for neuronal ROCK.
    Sezen SF; Lagoda G; Musicki B; Burnett AL
    J Sex Med; 2014 Sep; 11(9):2164-71. PubMed ID: 24919622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho-kinase inhibitor prevents acute injury against transient focal cerebral ischemia by enhancing the expression and function of GABA receptors in rats.
    Huang L; Li Q; Wen R; Yu Z; Li N; Ma L; Feng W
    Eur J Pharmacol; 2017 Feb; 797():134-142. PubMed ID: 28109911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasudil protects the heart against ischemia-reperfusion injury by attenuating endoplasmic reticulum stress and modulating SERCA activity: the differential role for PI3K/Akt and JAK2/STAT3 signaling pathways.
    Li Y; Zhu W; Tao J; Xin P; Liu M; Li J; Wei M
    PLoS One; 2012; 7(10):e48115. PubMed ID: 23118936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats.
    Ahmed LA; Darwish HA; Abdelsalam RM; Amin HA
    Mol Neurobiol; 2016 Aug; 53(6):3927-3938. PubMed ID: 26169112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
    Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
    J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium.
    Hamid SA; Bower HS; Baxter GF
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2598-606. PubMed ID: 17220176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Rho-kinase by fasudil restores the cardioprotection of ischemic postconditioninng in hypercholesterolemic rat heart.
    Wu N; Li W; Shu W; Lv Y; Jia D
    Mol Med Rep; 2014 Nov; 10(5):2517-24. PubMed ID: 25231456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity.
    Xin YL; Yu JZ; Yang XW; Liu CY; Li YH; Feng L; Chai Z; Yang WF; Wang Q; Jiang WJ; Zhang GX; Xiao BG; Ma CG
    Biosci Rep; 2015 Jul; 35(5):. PubMed ID: 26223433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
    Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
    Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho kinase inhibitor fasudil protects against β-amyloid-induced hippocampal neurodegeneration in rats.
    Song Y; Chen X; Wang LY; Gao W; Zhu MJ
    CNS Neurosci Ther; 2013 Aug; 19(8):603-10. PubMed ID: 23638992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wide therapeutic time window for Rho-kinase inhibition therapy in ischemic brain damage in a rat cerebral thrombosis model.
    Satoh S; Toshima Y; Hitomi A; Ikegaki I; Seto M; Asano T
    Brain Res; 2008 Feb; 1193():102-8. PubMed ID: 18187127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of fasudil hydrochloride post-conditioning on acute myocardial ischemia/reperfusion injury in rats.
    Jiang ZH; Zhang TT; Zhang JF
    Cardiol J; 2013; 20(2):197-202. PubMed ID: 23558879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective potential of fasudil mesylate in brain ischemia-reperfusion injury of rats.
    Li Q; Huang XJ; He W; Ding J; Jia JT; Fu G; Wang HX; Guo LJ
    Cell Mol Neurobiol; 2009 Mar; 29(2):169-80. PubMed ID: 18785000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROCK inhibition with fasudil promotes early functional recovery of spinal cord injury in rats by enhancing microglia phagocytosis.
    Fu PC; Tang RH; Wan Y; Xie MJ; Wang W; Luo X; Yu ZY
    J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):31-36. PubMed ID: 26838736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K/Akt pathway contributes to neuroprotective effect of Tongxinluo against focal cerebral ischemia and reperfusion injury in rats.
    Yu ZH; Cai M; Xiang J; Zhang ZN; Zhang JS; Song XL; Zhang W; Bao J; Li WW; Cai DF
    J Ethnopharmacol; 2016 Apr; 181():8-19. PubMed ID: 26805466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
    Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.